✦ LIBER ✦

Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study

✍ Scribed by Nina Keldsen; Ole Weis Bjerrum; Inger Marie S. Dahl; Aage Drivsholm; Jørgen Ellegaard; Ole Gadeberg; Peter Gimsing; Trude Grønvold; Mogens Mørk Hansen; Erik Hippe; Jon Lamvik; Bernt Ly; Alv Skarbøvik; Ingebrigt Talstad; Karen Thorling; Karl Wesenberg; Finn Wisløff for the Nordic Myeloma Study Group(NMSG)

Book ID: 114791737
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 496 KB
Volume: 51
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1993.tb01597.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RESISTANT MULTIPLE MYELOMA TREATED WITH

RESISTANT MULTIPLE MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP-REGIME)

✍ E. Ernst; A. Matrai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

RESISTANT MULTIPLE MYELOMA TREATED WITH

RESISTANT MULTIPLE MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP-REGIME)

✍ Erik Hippe; Niels Aage Tøffner Clausen; Peter Gimsing; Carsten Hædersdal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Refractory myelomatosis treated with mit

Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study

✍ Peter Gimsing; Ole W. Bjerrum; Eystein Brandt; Josrgen Ellegaard; Stein A. Evens 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Phase III Study of Ranimustine, Cyclopho

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

✍ Takeaki Takenaka; Kuniaki Itoh; Takayo Suzuki; Atae Utsunomiya; Shin Matsuda; Ta 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 116 KB

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

The treatment of multiple myeloma using

The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and α2β interferon versus VBMCP : Results of a phase III Eastern Cooperative Oncology Group Study E5A93

✍ Robert A. Kyle; Susanna Jacobus; William R. Friedenberg; Coenraad Frederik Slabb 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB